Gene-targeted therapies: Overview and implications

IF 2.8 3区医学 Q2 GENETICS & HEREDITY

American Journal of Medical Genetics Part C: Seminars in Medical Genetics Pub Date : 2023-03-02 DOI:10.1002/ajmg.c.32033

P J Brooks, Tiina K. Urv, Melissa A. Parisi

引用次数: 1

Abstract

Gene-targeted therapies (GTTs) are therapeutic platforms that are in principle applicable to large numbers of monogenic diseases. The rapid development and implementation of GTTs have profound implications for rare monogenic disease therapy development. This article provides a brief summary of the primary types of GTTs and a brief overview of the current state of the science. It also serves as a primer for the articles in this special issue.

查看原文本刊更多论文

基因靶向治疗:概述和意义

基因靶向治疗(gtt)是原则上适用于大量单基因疾病的治疗平台。gtt的快速发展和实施对罕见单基因疾病的治疗发展具有深远的意义。本文简要总结了gtt的主要类型，并简要概述了目前的科学状况。它也可以作为本特刊文章的入门。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

American Journal of Medical Genetics Part C: Seminars in Medical Genetics 医学-遗传学

CiteScore

7.00

自引率

0.00%

发文量

审稿时长

>12 weeks

期刊介绍： Seminars in Medical Genetics, Part C of the American Journal of Medical Genetics (AJMG) , serves as both an educational resource and review forum, providing critical, in-depth retrospectives for students, practitioners, and associated professionals working in fields of human and medical genetics. Each issue is guest edited by a researcher in a featured area of genetics, offering a collection of thematic reviews from specialists around the world. Seminars in Medical Genetics publishes four times per year.